Open: 24.12 Close: 24.07 Change: -0.05

Today's Summary

Ultragenyx Pharmaceutical (NASDAQ: RARE ) is set to give its latest quarterly earnings report on Tuesday, 2025-05-06. Analysts estimate that Ultragenx Pharmaceutical will report an earnings per share (EPS) of $-1.62. Investors are eagerly awaiting the announcement. Ultragenyx Pharmaceutical shares were down 43.96% at $19.16 at the time of publication on Monday. The companies in a press release on Monday said that neither study achieved statistical significance against the primary endpoints of reduction in annualized clinical fracture rate.